KATIE LOVETT: Open Payments
NPI 1033881446 · BALTIMORE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$731 in 42 payments from 14 companies in 2025. Trend: 2023 $1,573 · 2024 $1,240 · 2025 $731
Food & beverage: $731
| Company | Payments | Amount |
|---|---|---|
| Collegium Pharmaceutical, Inc. | 19 | $273 |
| SCILEX PHARMACEUTICALS INC. | 5 | $97 |
| ABBVIE INC. | 3 | $64 |
| MML US, Inc. | 3 | $63 |
| BIOTRONIK NRO, Inc. | 2 | $35 |
| VERTEX PHARMACEUTICALS INCORPORATED | 2 | $35 |
| Curonix LLC | 1 | $24 |
| Abbott Laboratories | 1 | $24 |
| Globus Medical, Inc. | 1 | $23 |
| Amgen Inc. | 1 | $22 |
Products named: Belbuca, ZTLido, ReActiv8, UBRELVY, Prospera, JOURNAVX, PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A, PROCLAIM.
Industry payments across MD — which companies pay providers there.
